🇨🇦 Aurinia Pharmaceuticals Inc.
Forum topic · AUPH · Company page: financials, ownership and filings
Join the discussion on Aurinia Pharmaceuticals Inc.
Loading…
Results announced on 30 October 2026
Aurinia Pharmaceuticals Inc. announced results on 30 October 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $84 million (up 14% from a year earlier) and net income of $32 million (level with a year earlier).
Mutual funds: 139 funds hold $238 million
139 mutual funds in 2 countries hold shares of Aurinia Pharmaceuticals Inc. worth $238 million, about 11.0% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 73 funds added shares and 48 sold; on balance they bought $26 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.